Zhengfei Zhu

机构：Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Shanghai Clinical Research Center · ORCID：0000-0001-7537-3619

发表论文 210 篇 · 总被引 3684 次 · h-index 31

代表论文

• Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial (2024 · Nature Communications · 被引 19)
• Identification of a novel subtype of SPP1 + macrophages expressing SIRPα: implications for tumor immune evasion and treatment response prediction (2024 · Experimental Hematology and Oncology · 被引 14)
• Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations (2024 · The Innovation · 被引 14)
• Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy (2024 · Cancer Immunology Immunotherapy · 被引 11)
• Radiation Dose–Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy (2025 · Clinical Cancer Research · 被引 8)
• Impact of Radiation on Exosomes in Regulating Tumor Immune Microenvironment (2024 · Advances in Radiation Oncology · 被引 8)